Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-28 Purchase |
2023-08-28 4:39 pm |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
14,705 | $6.7976 | $99,959 | 21,688 (Direct) |
View |
| 2023-02-08 Sale |
2023-02-10 4:55 pm |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
4,267 | $13.89 | $59,272 | 6,983 (Direct) |
View |
| 2020-07-09 Sale |
2020-07-10 4:06 pm |
Anika Therapeutics Inc. | ANIK | Loerop James EVP Business Development |
1,244 | $35.15 | $43,727 | 1,756 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-01 Exercise |
2025-02-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
33,500 | $0 | 549,606 (Direct) |
View |
| 2025-02-01 Tax Withholding |
2025-02-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
15,447 | $2.48 | 549,606 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 4:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
375,800 | $0 | 549,606 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 6:25 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
91,900 | $0 | 250,853 (Direct) |
View |
| 2024-12-31 Tax Withholding |
2025-01-03 6:25 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
40,664 | $2.48 | 250,853 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-03 6:25 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
55,000 | $0 | 250,853 (Direct) |
View |
| 2024-02-01 Tax Withholding |
2024-02-05 7:29 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
6,421 | $1.2 | 492,017 (Direct) |
View |
| 2024-02-01 Exercise |
2024-02-05 7:29 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
18,750 | $0 | 492,017 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 7:29 pm |
N/A 2034-01-31 |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
413,000 | $0 | 492,017 (Direct) |
View |
| 2023-02-01 Exercise |
2023-02-03 5:01 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
11,250 | $0 | 180,000 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:01 pm |
N/A 2033-01-31 |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
135,000 | $0 | 180,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-01 4:50 pm |
N/A 2032-01-31 |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2021-07-08 Exercise |
2021-07-12 4:15 pm |
N/A N/A |
Anika Therapeutics Inc. | ANIK | Loerop James EVP Business Development |
3,000 | $0 | 8,592 (Direct) |
View |
| 2021-07-08 Tax Withholding |
2021-07-12 4:15 pm |
N/A N/A |
Anika Therapeutics Inc. | ANIK | Loerop James EVP Business Development |
731 | $43.24 | 8,592 (Direct) |
View |
| 2021-03-09 Option Award |
2021-03-11 5:14 pm |
N/A N/A |
Anika Therapeutics Inc. | ANIK | Loerop James EVP Business Development |
23,507 | $0 | 23,507 (Direct) |
View |
| 2021-02-25 Exercise |
2021-03-01 5:19 pm |
N/A N/A |
Anika Therapeutics Inc. | ANIK | Loerop James EVP Business Development |
1,567 | $0 | 6,456 (Direct) |
View |
| 2020-07-08 Option Award |
2020-07-10 4:06 pm |
N/A N/A |
Anika Therapeutics Inc. | ANIK | Loerop James EVP Business Development |
3,000 | $0 | 1,756 (Direct) |
View |